MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with S

Sodium fluoride

Sodium fluoride 0.05% mouthwash sugar free

Unsuitable

Stability notes for Sodium fluoride 0.05% mouthwash sugar free

There are no stability notes for this medicine.

Suppliers

Colgate FluoriGard 0.05% daily dental rinse (Colgate-Palmolive (UK) Ltd)
Endekay 0.05% daily fluoride mouthrinse (Manx Healthcare Ltd)
Endekay 0.05% fluoride mouthrinse alcohol free (Manx Healthcare Ltd)

Sodium fluoride 0.619% dental paste sugar free

Unsuitable

Stability notes for Sodium fluoride 0.619% dental paste sugar free

There are no stability notes for this medicine.

Suppliers

Colgate Duraphat 2800ppm fluoride toothpaste (Colgate-Palmolive (UK) Ltd)
Fluoritop LF 2800ppm fluoride toothpaste (RX Farma)

Sodium fluoride 1.1% dental paste sugar free

Unsuitable

Stability notes for Sodium fluoride 1.1% dental paste sugar free

There are no stability notes for this medicine.

Suppliers (4) of Sodium fluoride 1.1% dental paste sugar free
Colgate Duraphat 5000ppm fluoride toothpaste (Colgate-Palmolive (UK) Ltd)
Colgate Duraphat 5000ppm fluoride toothpaste (Necessity Supplies Ltd)
Colgate Duraphat Protify 5000ppm fluoride toothpaste (Colgate-Palmolive (UK) Ltd)
Fluoritop HF 5000ppm fluoride toothpaste (RX Farma)

Sodium fluoride 20mg capsules

No stability information

Stability notes for Sodium fluoride 20mg capsules

There are no stability notes for this medicine.

Supplier

Sodium fluoride 20mg capsules (Special Order)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.